Cetuximab in first line treatment of metastatic colorectal cancer. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 13, n. 1S, p. 1–80, 2012. DOI: 10.7175/fe.v13i1S.305. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/305. Acesso em: 28 dec. 2025.